# Leflunomide for Idiopathic Pulmonary Hemosiderosis in Children

> **NCT05937191** · PHASE1,PHASE2 · RECRUITING · sponsor: **Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University** · enrollment: 34 (estimated)

## Conditions studied

- Idiopathic Pulmonary Hemosiderosis
- Leflunomide

## Interventions

- **DRUG:** Leflunomide
- **DRUG:** Steroid Drug

## Key facts

- **NCT ID:** NCT05937191
- **Lead sponsor:** Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2023-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05937191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05937191, "Leflunomide for Idiopathic Pulmonary Hemosiderosis in Children". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05937191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*